Federal contract award
W91YTZ21P0175
STRIPS ICHEM VELOCITY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $57.4K |
| Current contract value | $57.4K |
| Potential contract value / ceiling | $57.4K |
| Start date | Oct 1, 2021 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | May 28, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 28, 2026 | P00011 | $0 | IRISCELL URINALYSIS REAGENTS FOR FOX ARMY HEALTH CENTER, REDSTONE ARSENAL, ALABAMA. |
| Feb 19, 2026 | P00010 | $11.4K | IRISCELL URINALYSIS REAGENTS FOR FOX ARMY HEALTH CENTER, REDSTONE ARSENAL, ALABAMA. |
| Aug 22, 2025 | P00009 | $0 | IRISCELL URINALYSIS REAGENTS FOR FOX ARMY HEALTH CENTER, REDSTONE ARSENAL, ALABAMA. |
| Oct 29, 2024 | P00008 | $11.4K | TRJ UMOD FUNDING IRISCELL REAGENTS FAHC |
| Aug 27, 2024 | P00007 | $0 | FY25 SAF OY3 IRIS URINALYSIS REAGENT |
| Nov 9, 2023 | P00006 | $11.4K | FY24 FUNDING MODIFICATION |
| Jul 7, 2023 | P00005 | $0 | FY24 SAF OY2 IRIS SYSTEM 1500 REAGENTS |
| Feb 24, 2023 | P00004 | $274 | MOD FUND FY23 |
| Oct 18, 2022 | P00003 | $11.4K | MOD FUND FY23 |
| Jun 8, 2022 | P00002 | $0 | MOD OPT 1 FY23 |
| Nov 5, 2021 | P00001 | $11.4K | FY22 FUNDING MOD IRIS SYSTEM PR # 11645600-0001 |
| Sep 10, 2021 | 0 | $0 | STRIPS ICHEM VELOCITY |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.